Literature DB >> 8611544

High-level expression and characterization of a purified 142-residue polypeptide of the prion protein.

I Mehlhorn1, D Groth, J Stöckel, B Moffat, D Reilly, D Yansura, W S Willett, M Baldwin, R Fletterick, F E Cohen, R Vandlen, D Henner, S B Prusiner.   

Abstract

The major, and possible only, component of the infectious prion is the scrapie prion protein (PrPSc); the protease resistant core of PrPSc is PrP 27-30, a protein of approximately 142 amino acids. PrPSc is derived from the cellular PrP isoform (PrPC) by a post-transliatonal process in which a profound conformational change occurs. Syrian hamster (SHa) PrP genes of varying length ranging from the N- and C- terminally truncated 90-228 up to the full-length mature protein 23-231 were inserted into various secretion and intracellular expression vectors that were transformed into Escherichia coli deficient for proteases. Maximum expression was obtained for a truncated SHaPrP containing residues 90-231, which correspond to the sequence of PrP 27-30; disruption of the bacteria using a microfluidizer produced the highest yields of this protein designated rPrP. After solubilization of rPrP in 8 M GdnHC1, it was purified by size exclusion chromatography and reversed phase chromatography. During purification the recovery was approximately 50%, and from each liter of E. coli culture, approximately 50 mg of purified rPrP was obtained. Expression of the longer species containing the basic N-terminal region was less successful and was not pursued further. The primary structure of rPrP was verified by Edman sequencing and mass spectrometry, and secondary structure determined by circular dichroism and Fourier transform infrared spectroscopy. When rPrP was purified under reducing conditions, it had a high beta-sheet content and relatively low solubility similar to PrPSc, particularly at pH values > 7. Refolding of rPrP by oxidation to form a disulfide bond between the two Cys residues of this polypeptide produced a soluble protein with a high alpha-helical content similar to PrPC. These multiple conformations of rPrP are reminiscent of the structural plurality that characterizes the naturally occurring PrP isoforms. The high levels of purified rPrP which can now be obtained should facilitate determination of the multiple tertiary structures that Prp can adopt.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611544     DOI: 10.1021/bi952965e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  48 in total

1.  Affinity-tagged miniprion derivatives spontaneously adopt protease-resistant conformations.

Authors:  S Supattapone; H O Nguyen; T Muramoto; F E Cohen; S J DeArmond; S B Prusiner; M Scott
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  The role of dimerization in prion replication.

Authors:  Peter Tompa; Gábor E Tusnády; Peter Friedrich; István Simon
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

3.  Conformation-dependent high-affinity monoclonal antibodies to prion proteins.

Authors:  Larry H Stanker; Ana V Serban; Elisa Cleveland; Robert Hnasko; Azucena Lemus; Jiri Safar; Stephen J DeArmond; Stanley B Prusiner
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

4.  The peculiar nature of unfolding of the human prion protein.

Authors:  Ilia V Baskakov; Giuseppe Legname; Zygmunt Gryczynski; Stanley B Prusiner
Journal:  Protein Sci       Date:  2004-02-06       Impact factor: 6.725

Review 5.  Emergence and natural selection of drug-resistant prions.

Authors:  James Shorter
Journal:  Mol Biosyst       Date:  2010-04-27

6.  Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein.

Authors:  R A Williamson; D Peretz; N Smorodinsky; R Bastidas; H Serban; I Mehlhorn; S J DeArmond; S B Prusiner; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 7.  An emerging concept of prion infections as a form of transmissible cerebral amyloidosis.

Authors:  Omar Lupi; Marcius Achiame Peryassu
Journal:  Prion       Date:  2007 Oct-Dec       Impact factor: 3.931

8.  Purification and Fibrillation of Full-Length Recombinant PrP.

Authors:  Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  Methods Mol Biol       Date:  2017

9.  Novel epitopes identified by anti-PrP monoclonal antibodies produced following immunization of Prnp0/0 Balb/cJ mice with purified scrapie prions.

Authors:  Larry H Stanker; Miles C Scotcher; Alice Lin; Jeffery McGarvey; Stanley B Prusiner; Robert Hnasko
Journal:  Hybridoma (Larchmt)       Date:  2012-10

10.  Structural changes of membrane-anchored native PrP(C).

Authors:  Kerstin Elfrink; Julian Ollesch; Jan Stöhr; Dieter Willbold; Detlev Riesner; Klaus Gerwert
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.